Biologics

Orthofix's Virtuos Lyograft allograft was debuted by neurosurgeon Thomas Ellis, MD.

NovaBone, a biologic medtech company focused on orthopedic and dental products, hired Brian Carlisle as CEO.

From a notable stem cell study to newly launched products, here are eight updates in regenerative orthopedic medicine:

Ossifix Orthopedics will launch its demineralized bone matrix, made from 100 percent human bone tissue in August.

The Pediatric Orthopedic Center in Cedar Knolls, N.J., became the first pediatric-only orthopedic practice in its region to add the Bear implant for ACL restoration.

Scientists in the U.K. have found that a new drug being tested for cancer therapy may also be able to reduce damage in patients with spinal cord injuries.

Spiderwort, a startup developing cellulose-based tissue scaffolding to treat acute spinal cord injuries, has secured $13.2 million through a series A financing round, the company said July 12.

Regenerative medicine in orthopedics has developed in the first half of 2022, and many surgeons have a positive outlook toward it.

AlloSource added the AlloFuse microfibers demineralized bone allograft to its product line.

Istos Biologics launched the Influx Fibrant line of 100 percent cortical allograft products.